Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Modeling islet enhancers using deep learning identifies candidate causal variants at loci associated with T2D and glycemic traits

View ORCID ProfileSanjarbek Hudaiberdiev, D. Leland Taylor, Wei Song, Narisu Narisu, Redwan M. Bhuiyan, Henry J. Taylor, Tingfen Yan, Amy J. Swift, Lori L. Bonnycastle, DIAMANTE Consortium, Michael L. Stitzel, Michael R. Erdos, Ivan Ovcharenko, Francis S. Collins
doi: https://doi.org/10.1101/2022.05.13.22275035
Sanjarbek Hudaiberdiev
1Computational Biology Branch, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sanjarbek Hudaiberdiev
D. Leland Taylor
2Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Song
1Computational Biology Branch, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Narisu Narisu
2Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Redwan M. Bhuiyan
3The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
4Department of Genetics and Genome Sciences, University of Connecticut, Farmington, CT 06032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry J. Taylor
2Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
5Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tingfen Yan
2Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy J. Swift
2Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lori L. Bonnycastle
2Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael L. Stitzel
3The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
4Department of Genetics and Genome Sciences, University of Connecticut, Farmington, CT 06032, USA
6Institute of Systems Genomics, University of Connecticut, Farmington, CT 06032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael R. Erdos
2Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mikee@mail.nih.gov ovcharei@ncbi.nlm.nih.gov francis.collins@nih.gov
Ivan Ovcharenko
1Computational Biology Branch, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mikee@mail.nih.gov ovcharei@ncbi.nlm.nih.gov francis.collins@nih.gov
Francis S. Collins
2Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mikee@mail.nih.gov ovcharei@ncbi.nlm.nih.gov francis.collins@nih.gov
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Genetic association studies have identified hundreds of independent signals associated with type 2 diabetes (T2D) and related traits. Despite these successes, the identification of specific causal variants underlying a genetic association signal remains challenging. In this study, we describe a deep learning method to analyze the impact of sequence variants on enhancers. Focusing on pancreatic islets, a T2D relevant tissue, we show that our model learns islet-specific transcription factor (TF) regulatory patterns and can be used to prioritize candidate causal variants. At 101 genetic signals associated with T2D and related glycemic traits where multiple variants occur in linkage disequilibrium, our method nominates a single causal variant for each association signal, including three variants previously shown to alter reporter activity in islet-relevant cell types. For another signal associated with blood glucose levels, we biochemically test all candidate causal variants from statistical fine-mapping using a pancreatic islet beta cell line and show biochemical evidence of allelic effects on TF binding for the model-prioritized variant. To aid in future research, we publicly distribute our model and islet enhancer perturbation scores across ∼67 million genetic variants. We anticipate that deep learning methods like the one presented in this study will enhance the prioritization of candidate causal variants for functional studies.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was funded in part by United States National Institutes of Health grants 1-ZIA-HG000024 (to F.S.C.), 1-ZIA-LM200881-12 (to I.O.), R01DK118011 (to M.L.S.), and the Department of Defense Peer-Reviewed Medical Research Program grant W81XWH-18-0401 (to M.L.S.).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The models from this study (architecture and weights), islet enhancer locations, PAS/DAS locations, and IEP scores for gnomAD SNPs are available through zenodo (https://doi.org/10.5281/zenodo.6463875).

https://doi.org/10.5281/zenodo.6463875

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted May 16, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Modeling islet enhancers using deep learning identifies candidate causal variants at loci associated with T2D and glycemic traits
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Modeling islet enhancers using deep learning identifies candidate causal variants at loci associated with T2D and glycemic traits
Sanjarbek Hudaiberdiev, D. Leland Taylor, Wei Song, Narisu Narisu, Redwan M. Bhuiyan, Henry J. Taylor, Tingfen Yan, Amy J. Swift, Lori L. Bonnycastle, DIAMANTE Consortium, Michael L. Stitzel, Michael R. Erdos, Ivan Ovcharenko, Francis S. Collins
medRxiv 2022.05.13.22275035; doi: https://doi.org/10.1101/2022.05.13.22275035
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Modeling islet enhancers using deep learning identifies candidate causal variants at loci associated with T2D and glycemic traits
Sanjarbek Hudaiberdiev, D. Leland Taylor, Wei Song, Narisu Narisu, Redwan M. Bhuiyan, Henry J. Taylor, Tingfen Yan, Amy J. Swift, Lori L. Bonnycastle, DIAMANTE Consortium, Michael L. Stitzel, Michael R. Erdos, Ivan Ovcharenko, Francis S. Collins
medRxiv 2022.05.13.22275035; doi: https://doi.org/10.1101/2022.05.13.22275035

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9757)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2303)
  • Geriatric Medicine (221)
  • Health Economics (462)
  • Health Informatics (1553)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11631)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2139)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2172)
  • Public and Global Health (4645)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)